MTHFR rs1801133: Understanding the C677T Variant
The rs1801133 variant, commonly known as C677T, is a well-studied genetic change in the MTHFR gene. It is associated with the production of a thermolabile enzyme that may influence how the body processes folate and regulates homocysteine levels.
What each genotype means
Typical enzyme activity
This is the most common genotype for this variant. Research indicates that individuals with this profile typically maintain standard MTHFR enzyme function, which is important for folate metabolism and homocysteine regulation.
This is the most frequent genotype globally, though exact percentages vary significantly by ancestry.
Reduced enzyme activity
Carrying one copy of the T allele is associated with a modest reduction in MTHFR enzyme activity compared to the CC genotype. While this may influence how your body processes folate, it is generally not considered a clinical concern; discuss your nutritional status and folate intake with your healthcare provider.
This genotype is common, found in a significant portion of the global population across various ethnic groups.
Lower enzyme activity
Individuals with this genotype, sometimes referred to as the 677TT variant, may experience lower MTHFR enzyme activity and potentially higher homocysteine levels, particularly if folate intake is insufficient. Research suggests this may be relevant during periods of high folate demand, such as pregnancy, but it is not a diagnostic indicator of disease. Please consult with your clinician or pharmacist regarding your folate status and any necessary dietary adjustments.
This genotype is less common than the others, with frequencies varying widely by ancestry, ranging from approximately 1% to over 10% in different populations.
What is the rs1801133 Variant?
The rs1801133 variant, frequently referred to as C677T, is a single-nucleotide polymorphism located within the MTHFR gene. In this specific position, a cytosine (C) is replaced by a thymine (T). This change results in an amino acid substitution (alanine to valine) in the resulting protein. Because this variant is extremely common in many human populations, it is classified as a polymorphism rather than a rare mutation. It sits on chromosome 1 and has been the subject of extensive research regarding its impact on enzyme stability and metabolic function. While it is a frequent topic of discussion in health and wellness circles, it is important to understand that carrying this variant is a normal part of human genetic diversity and does not inherently signify a disease state.
The Role of the MTHFR Gene
The MTHFR gene provides instructions for making the enzyme methylenetetrahydrofolate reductase. This enzyme plays a critical role in the methyl cycle, a biochemical pathway essential for converting dietary folate and synthetic folic acid into 5-methyltetrahydrofolate (5-MTHF). This active form of folate is necessary for the body to synthesize DNA, repair cells, and convert the amino acid homocysteine into methionine. When the MTHFR enzyme functions optimally, it helps maintain balanced homocysteine levels in the blood. The rs1801133 variant produces an enzyme that is 'thermolabile,' meaning it is less stable and has reduced activity, particularly at higher temperatures. This reduction in efficiency is why researchers have long investigated whether this variant contributes to elevated homocysteine levels or impacts how individuals respond to different forms of folate in their diet.
Research Associations and Evidence Strength
Research into rs1801133 has produced a vast body of literature, yet the clinical significance remains nuanced. Studies have consistently linked the homozygous (TT) genotype to a mildly increased risk of hyperhomocysteinemia, a condition characterized by higher-than-normal levels of homocysteine in the blood. Some meta-analyses have suggested a modest association between this variant and an increased risk of certain conditions, such as ischemic stroke or neural tube defects, though the evidence is often described as limited or mixed. Crucially, many of these associations are highly dependent on environmental factors, particularly dietary folate intake. Public health organizations, such as the CDC, emphasize that folic acid intake is a more significant determinant of blood folate levels than the presence of this variant. Because the evidence is complex and often ancestry-specific, it is not used as a standalone diagnostic tool for clinical decision-making.
Population Frequency
The rs1801133 variant is widespread across global populations, though its frequency varies significantly by ancestry. In many populations, the T allele is common, meaning a large percentage of the global population carries at least one copy. For example, data from the CDC indicates that the frequency of the T allele and the distribution of CC, CT, and TT genotypes differ notably between groups such as Non-Hispanic White, Non-Hispanic Black, and Mexican American populations. Because this variant is so common, it is considered a normal variation in the human genome rather than a rare genetic disorder. Understanding these frequencies helps researchers contextualize the variant's impact, as what is considered a 'typical' genotype in one population may be less common in another.
What You Can and Cannot Do With This Information
Genetic information regarding rs1801133 should be viewed as one piece of a much larger health puzzle. You cannot use this information to diagnose yourself with a medical condition or to predict specific health outcomes. Because the phenotypic impact of this variant is heavily influenced by diet and lifestyle, it is not a deterministic marker for disease. If you are concerned about your homocysteine levels or folate status, the most effective approach is to consult with a healthcare provider or a registered dietitian. They can assess your overall health, dietary habits, and blood markers to provide personalized guidance. Never make changes to your medication or supplement regimen based on genetic test results without first discussing them with your clinician or pharmacist, as they can ensure any interventions are safe and appropriate for your specific health needs.
How common is this variant?
The rs1801133 variant is common globally, with the T allele frequency typically ranging between 0.10 and 0.45 depending on the population. Genotype frequencies vary significantly by ancestry, with the TT genotype being more prevalent in some groups than others.
Frequently asked questions
Is the MTHFR rs1801133 variant a disease?
No, the rs1801133 variant is not a disease. It is a common genetic polymorphism that affects the efficiency of an enzyme, and most people who carry it live healthy lives without any clinical symptoms.
Should I take special supplements for my MTHFR variant?
You should not start or change any supplement regimen based on your MTHFR status without consulting a doctor. A healthcare professional can determine if you have a nutritional deficiency that requires supplementation.
Does this variant mean I cannot process folic acid?
Current research indicates that individuals with MTHFR variants can still process folic acid. Dietary intake of folate and folic acid is generally more important for maintaining healthy blood levels than the presence of this variant.
How do I get tested for MTHFR?
MTHFR testing is often included in direct-to-consumer genetic panels, but it is not routinely recommended by medical organizations for general health screening. If you have specific health concerns, discuss the necessity of testing with your primary care physician.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1801132?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MTHFR
Variant in the MTHFR locus frequently studied in association with folate metabolism and homocysteine levels.
MTHFR missense variant (c.1793G>A, p.Arg594Gln) commonly evaluated alongside canonical variants for folate metabolism and hyperhomocysteinemia predisposition.
Functional polymorphism influencing homocysteine dynamics and vascular endothelial recovery during high-intensity training.
Common variant (C677T) influencing folate metabolism and plasma homocysteine levels.
The MTHFR 677C>T (Ala222Val) variant encodes a thermolabile enzyme with reduced activity. While associated with elevated homocysteine levels in the presence of low folate, major professional guidelines (e.g., ACMG) advise against routine clinical testing for cardiovascular or thrombophilia risk due to lack of clinical utility.
Rare functional missense variant in MTHFR (p.Arg157Gln) associated with reduced folate pathway enzyme activity.